REZLIDHIA 150 mg/1
olutasidenib · CAPSULE · Rigel Pharmaceuticals, Inc.
No Recall History
Plain English
REZLIDHIA is a capsule containing olutasidenib at 150 mg/1, taken oral. Manufactured by Rigel Pharmaceuticals, Inc..
Key Facts
- Brand Name
- REZLIDHIA
- Generic Name
- olutasidenib
- NDC Code (Product)
71332-005- Manufacturer
- Rigel Pharmaceuticals, Inc.
- Strength
- 150 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA215814
- Marketing Start
- 12/01/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is REZLIDHIA used for?
REZLIDHIA contains olutasidenib. It is a capsule taken oral. Consult your doctor for specific uses.
Is REZLIDHIA a controlled substance?
REZLIDHIA is not classified as a controlled substance by the DEA.
What is the generic name for REZLIDHIA?
The generic name for REZLIDHIA is olutasidenib. There are no other listed brand versions of olutasidenib.
What is the NDC code for REZLIDHIA 150 mg/1?
The NDC (National Drug Code) for REZLIDHIA 150 mg/1 is 71332-005, listed by Rigel Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)